195 research outputs found
The effect of a diet supplement containing S-acetyl-glutathione (SAG) and other antioxidant natural ingredients on glutathione peroxidase in healthy dogs: a pilot study
Temporal variations in the usefulness of normalised difference vegetation index as a predictor for Ixodes ricinus (Acari: Ixodidae) in a Borrelia lusitaniae focus in Tuscany, central Italy
Transmission dynamics of Borrelia lusitaniae and Borrelia afzelii among Ixodes ricinus, lizards, and mice in Tuscany, Central Italy
The epidemiology of diphtheria in Haiti, December 2014-June 2021: A spatial modeling analysis
BACKGROUND: Haiti has been experiencing a resurgence of diphtheria since December 2014. Little is known about the factors contributing to the spread and persistence of the disease in the country. Geographic information systems (GIS) and spatial analysis were used to characterize the epidemiology of diphtheria in Haiti between December 2014 and June 2021. METHODS: Data for the study were collected from official and open-source databases. Choropleth maps were developed to understand spatial trends of diphtheria incidence in Haiti at the commune level, the third administrative division of the country. Spatial autocorrelation was assessed using the global Moran's I. Local indicators of spatial association (LISA) were employed to detect areas with spatial dependence. Ordinary least squares (OLS) and geographically weighted regression (GWR) models were built to identify factors associated with diphtheria incidence. The performance and fit of the models were compared using the adjusted r-squared (R2) and the corrected Akaike information criterion (AICc). RESULTS: From December 2014 to June 2021, the average annual incidence of confirmed diphtheria was 0.39 cases per 100,000 (range of annual incidence = 0.04-0.74 per 100,000). During the study period, diphtheria incidence presented weak but significant spatial autocorrelation (I = 0.18, p<0.001). Although diphtheria cases occurred throughout Haiti, nine communes were classified as disease hotspots. In the regression analyses, diphtheria incidence was positively associated with health facility density (number of facilities per 100,000 population) and degree of urbanization (proportion of urban population). Incidence was negatively associated with female literacy. The GWR model considerably improved model performance and fit compared to the OLS model, as indicated by the higher adjusted R2 value (0.28 v 0.15) and lower AICc score (261.97 v 267.13). CONCLUSION: This study demonstrates that GIS and spatial analysis can support the investigation of epidemiological patterns. Furthermore, it shows that diphtheria incidence exhibited spatial variability in Haiti. The disease hotspots and potential risk factors identified in this analysis could provide a basis for future public health interventions aimed at preventing and controlling diphtheria transmission
Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico
Longitudinal Dengue (DENV) data generated patterns indicative of the resulting introduction and transmission patterns of chikungunya (CHIKV) and Zika virus (ZIKV), leading to important insights for the surveillance and targeted control of emerging Aedes-borne viruses. About 42% of the 40,028 DENV cases reported during 2008–2015 clustered in 27% of Merida (Mexico), and these clustering areas were where the first CHIKV and ZIKV cases were reported in 2015 and 2016. Findings from this article open a window to the consideration of spatially-targeted approaches for delivery of vector control interventions and surveillance.National Science FoundationOffice of Infectious Disease, Bureau for Global Health, U.S. Agency for International DevelopmentUS Centers for Disease Control and Preventio
Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa.
Artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ) are the most commonly used artemisinin-based combination therapies (ACT) for treatment of Plasmodium falciparum in Africa. Both treatments remain efficacious, but single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum multidrug resistance 1 (Pfmdr1) gene may compromise sensitivity. AL and AS-AQ exert opposing selective pressures: parasites with genotype 86Y, Y184 and 1246Y are partially resistant to AS-AQ treatment, while N86, 184 F and D1246 are favoured by AL treatment. Through a systematic review, we identified 397 surveys measuring the prevalence of Pfmdr1 polymorphisms at positions 86 184 or 1246 in 30 countries in Africa. Temporal trends in SNP frequencies after introduction of AL or AS-AQ as first-line treatment were analysed in 32 locations, and selection coefficients estimated. We examined associations between antimalarial policies, consumption, transmission intensity and rate of SNP selection. 1246Y frequency decreased on average more rapidly in locations where national policy recommended AL (median selection coefficient(s) of -0.083), compared with policies of AS-AQ or both AL and AS-AQ (median s=-0.035 and 0.021, p<0.001 respectively). 86Y frequency declined markedly after ACT policy introduction, with a borderline significant trend for a more rapid decline in countries with AL policies (p=0.055). However, these trends could also be explained by a difference in initial SNP frequencies at the time of ACT introduction. There were non-significant trends for faster selection of N86 and D1246 in areas with higher AL consumption and no trend with transmission intensity. Recorded consumption of AS-AQ was low in the locations and times Pfmdr1 data were collected. SNP trends in countries with AL policies suggest a broad increase in sensitivity of parasites to AS-AQ, by 7-10 years after AL introduction. Observed rates of selection have implications for planning strategies to cycle drugs or use multiple first-line therapies to maintain drug efficacy
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003–2015: a modelling study using data from national surveys
Background Artemisinin-based combination therapies (ACTs) are the most effective treatment for uncomplicated
Plasmodium falciparum malaria infection. A commonly used indicator for monitoring and assessing progress in
coverage of malaria treatment is the proportion of children younger than 5 years with reported fever in the previous
14 days who have received an ACT. We propose an improved indicator that incorporates parasite infection status (as
assessed by a rapid diagnostic test [RDT]), which is available in recent household surveys. In this study we estimated
the annual proportion of children younger than 5 years with fever and a positive RDT in Africa who received an ACT
in 2003–15.
Methods Our modelling study used cross-sectional data on treatment for fever and RDT status for children younger
than 5 years compiled from all nationally available representative household surveys (the Malaria Indicator Surveys,
Demographic and Health Surveys, and Multiple Indicator Cluster Surveys) across sub-Saharan Africa between 2003
and 2015. Estimates for the proportion of children younger than 5 years with a fever within the previous 14 days and
P falciparum infection assessed by RDT who received an ACT were incorporated in a generalised additive mixed
model, including data on ACT distributions, to estimate coverage across all countries and time periods. We did
random effects meta-analyses to examine individual, household, and community effects associated with ACT coverage.
Findings We obtained data on 201 704 children younger than 5 years from 103 surveys (22 MIS, 61 DHS, and 20 MICS)
across 33 countries. RDT results were available for 40 of these surveys including 40 261 (20%) children, and we
predicted RDT status for the remaining 161 443 (80%) children. Our results showed that ACT coverage in children
younger than 5 years with a fever and P falciparum infection increased across sub-Saharan Africa in 2003–15, but even
in 2015, only 19·7% (95% CI 15·6–24·8) of children younger than 5 years with a fever and P falciparum infection
received an ACT. In meta-analyses, children younger than 5 years were more likely to receive an ACT for fever and
P falciparum infection if they lived in an urban area (vs rural area; odds ratio [OR] 1·18, 95% CI 1·06–1·31), had
household wealth above the national median (vs wealth below the median; OR 1·26, 1·16–1·39), had a caregiver with
any education (vs no education; OR 1·31, 1·22–1·41), had a household insecticide-treated net (ITN; vs no ITN; OR 1·21,
1·13–1·29), were older than 2 years (vs ≤2 years; OR 1·09, 1·01–1·17), or lived in an area with a higher mean
P falciparum prevalence in children aged 2–10 years (OR 1·12, 1·02–1·23). In the subgroup of children for whom
treatment was sought, those who sought treatment in the public sector were more likely to receive an ACT (vs the
private sector; OR 3·18, 2·67–3·78).
Interpretation Despite progress during the 2003–15 malaria programme, ACT treatment for children with malaria
remains unacceptably low. More work is needed at the country level to understand how health-care access, service
delivery, and ACT supply might be improved to ensure appropriate treatment for all children with malaria
Studies on potential agents of mastitis in udders from small ruminants regularly slaughtered in Piemonte Region, North-Western Italy (part II): evaluation of antimicrobial resistance
- …